PhD Founder Brief – Archive

Global intelligence for PhD founders: what’s shifting in research, capital, and talent, and what it means for your venture.

The world of research commercialization moves quickly.

University IP policies are shifting. Deep-tech investment is concentrating in specific sectors and geographies. Talent mobility is reshaping who builds founding teams and where. Sovereign research funds are changing the non-dilutive funding landscape in ways many PhD founders don’t yet understand.

The PhD Founder Brief tracks what’s moving globally β€” in research funding, IP reform, capital flows, and talent dynamics β€” and translates it into one practical insight per week for doctoral entrepreneurs.

If you’re building a venture from your research, or an institution that supports them, these shifts can determine to success or failure.

PhD Founder Brief is not a trend report. It doesn’t provide generic startup advice. Its focus is providing global intelligence on what actually matters for PhD and research-backed founders building right now.

All Issues

#17 β€” Asian Deep Tech: An Honest Map for Spinout Founders (Forthcoming)
South Korea, Japan, China, and Singapore β€” four ecosystems, four entry points, one sequencing logic.
[Read on Substack β†’]

#16 β€” Brilliant Science. Empty Chair.
In a university spinout, the co-founder decision involves three parties β€” not two.
[Read on Substack β†’]

#15 β€” Your University Signed First. Now Your Investor Wants To.
Most founders negotiate the valuation. Focus on everything else.
[Read on Substack β†’]

#14 β€” China: The Most Misread Deep Tech Market
Most founders either romanticize China or avoid it entirely. Both are costly mistakes.
[Read on Substack β†’]

#13 β€” The Evidence-Based Venture Framework
The commercialization sequence built specifically for research-backed ventures β€” and the PROVE sequence.
[Read on Substack β†’]

#12 β€” The Regulatory Roadmap
Your compliance strategy is your funding strategy.
[Read on Substack β†’]

#11 β€” Your Patent Is Not Your Moat
The TTO filed the base patent. The moat you build on top of it is yours.
[Read on Substack β†’]

#10 β€” Leveraging The Venture Client Model
Run the pilot before you set the equity terms.
[Read on Substack β†’]

#9 β€” MENA, Israel and Your University’s Deep Tech Door
Gulf capital, Israeli venture infrastructure, and the research alliance most PhD founders have never activated.
[Read on Substack β†’]

#8 β€” The 63-Year Clause
What one term sheet taught me about structure before capital.
[Read on Substack β†’]

#7 β€” The Spinout Negotiation
What your TTO negotiation determines β€” and what most PhD founders never read carefully enough.
[Read on Substack β†’]

#6 β€” The Deep Tech Angel
Who funds deep tech at the earliest stage β€” and what they actually need to see.
[Read on Substack β†’]

#5 β€” The World’s Top Deep Tech Spinout University
ETH Zurich’s 192-startup model and what it means for every other institution.
[Read on Substack β†’]

#4 β€” The Non-Dilutive Playbook
$6.3B SBIR/STTR, €1.4B EIC, $5B+ MENA. How to stack the capital before you need it.
[Read on Substack β†’]

#3 β€” Lost in Translation
The investor fluency gap is structural. Here’s how to close it.
[Read on Substack β†’]

#2 β€” The Sovereign Lab: Why Singapore Wants your PhD
Singapore’s $37B RIE2030 plan and what it means for deep tech founders.
[Read on Substack β†’]

#1 β€” China Just Redefined the PhD. The Rest of the World Hasn’t Caught Up Yet.
What China’s “practical” PhD means for innovation and deep tech.
[Read on Substack β†’

Five Content Pillars

  • IP and Tech Transfer β€” TTO negotiations, university equity terms, spinout structuring
  • Capital Stack Strategy β€” non-dilutive to dilutive sequencing, angels, VC, sovereign funds
  • Commercial Proof β€” venture client model, regulatory pathways, pilot agreements
  • Term Sheet and Governance β€” Series A mechanics, board composition, co-founder equity
  • Research Commercialization Models β€” what’s working across US, EU, Asia

Who Writes this?

Todd Maurer β€” founder of Edunomix, owner of VersatilePhD, and 25-year practitioner at the intersection of doctoral expertise and venture strategy across emerging markets, deep tech, edtech, health tech and research commercialization.

How Each Issue Is Structured

Each newsletter issue uses a three-part format:

01🌐  THE GLOBAL SIGNAL One macro trend shaping research commercialization β€” a policy shift, a capital move, a talent dynamic, a funding change.
02πŸ”¬  WHAT IT MEANS FOR PhD FOUNDERS The practical implication for someone commercializing research right now. Not commentary β€” translation.
03βœ…  ONE ACTION A concrete step you can take this week based on the signal. Specific, not generic.

Read the latest issue β†’ edunomix.substack.com

Trusted by PhD and MD professionals from the VersatilePhD community, a global network of over 120,000 PhD-trained professionals.

One insight per week. No spam. Unsubscribe anytime.